The antiviral drug Paxlovid reduces the risk of getting long COVID
The antiviral medication Paxlovid seems to reduce the chance of developing long COVID, researchers report. In a large study of veterans’ medical records, Paxlovid lowered a person’s chance of landing in the hospital or dying from all causes in the six months following a COVID-19 infection. And the drug reduced the risk of developing 10 of 13 long-term health problems, researchers report March 23 in JAMA Internal Medicine.
Recent Posts
San Antonio City Council tentatively agrees to funding deal for new Spurs arena
Cooking Up Conversation: Celebrating with Ohio Crawford of Backyard on Broadway and Dibs Mixers
Majority on San Antonio City Council reject mayor's item calling for pause on Spurs negotiations
Health insurance carriers request raising ACA premiums by more than 20% on average in Texas
Why is Texas Ag Commissioner Sid Miller posting puppy play?
Combative U.S. Rep. Chip Roy jumps into crowded race for Texas Attorney General
Mayor Gina Ortiz Jones interrogates Spurs' Peter Holt as sparks fly at Project Marvel meeting
Line wraps around City Hall as debate over Project Marvel, Spurs arena gets underway
Texas House passes GOP redistricting map that would carve out five more seats for Trump
San Antonio man pleads guilty to federal charge that he threatened Trump in Facebook post
"My job is to find and attract mastery-based agents to the office, protect the culture, and make sure everyone is happy! "